Wird geladen...
New agents for AML and MDS
The heterogeneity of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) has led to a multiplicity of treatments, from cytotoxic agents to signal transduction modulators, cell cycle inhibitors, and epigenetic therapies. While some have shown promising initial results, the outlook for AM...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2009
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2793080/ https://ncbi.nlm.nih.gov/pubmed/19959100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2009.08.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|